BioNTech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 76.25% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
42.8%	AT Impf GmbH	102,489,101	R$70.6b	-1.5%	no data
17.2%	Ugur Sahin	41,295,728	R$28.5b	0%	no data
3.47%	Baillie Gifford & Co.	8,308,071	R$5.7b	0.38%	0.41%
2.49%	FMR LLC	5,979,545	R$4.1b	770%	0.04%
1.88%	PRIMECAP Management Company	4,516,518	R$3.1b	-5.7%	0.37%
1.82%	Flossbach & Von Storch Vermoegensmanagement AG	4,359,607	R$3.0b	-0.45%	1.27%
0.86%	BlackRock, Inc.	2,071,934	R$1.4b	9.31%	no data
0.81%	Capital Research and Management Company	1,951,606	R$1.3b	-0.09%	0.01%
0.75%	Temasek Holdings (Private) Limited	1,807,232	R$1.2b	0%	0.18%
0.5%	Salvia GmbH	1,193,651	R$822.6m	0%	no data
0.39%	Candriam, Société En Commandite Par Actions	927,164	R$639.0m	60.1%	0.3%
0.38%	Ozlem Tureci	913,247	R$629.4m	0%	no data
0.34%	Sean Marett	815,263	R$561.8m	0%	no data
0.31%	Sierk Poetting	754,784	R$520.1m	0%	no data
0.27%	Morgan Stanley, Investment Banking and Brokerage Investments	653,618	R$450.4m	-41.2%	0.01%
0.27%	Altrinsic Global Advisors, LLC	652,706	R$449.8m	-3.48%	2.12%
0.26%	Balyasny Asset Management L.P.	620,466	R$427.6m	36.1%	0.18%
0.21%	Fred Alger Management, LLC	500,844	R$345.1m	0%	0.25%
0.2%	Acatis Anlageberatung fur Investmentfonds GmbH	486,632	R$335.4m	-0.05%	3.76%
0.2%	Deka Investment GmbH	481,397	R$331.8m	12.6%	0.05%
0.19%	First Trust Advisors LP	451,192	R$310.9m	10.3%	0.04%
0.17%	Quinn Opportunity Partners LLC	404,500	R$278.7m	-40.8%	4.1%
0.17%	Voloridge Investment Management, LLC	400,306	R$275.9m	48.3%	0.16%
0.16%	Point72 Asset Management, L.P.	389,238	R$268.2m	-15.7%	0.11%
0.16%	Amundi Asset Management SAS	372,756	R$256.9m	33.6%	0.01%